Global Neurointerventional Devices Market Research Report
The Global Neurointerventional Devices Market, mainly driven by gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. The global neurointerventional devices market is estimated to be $1544.79 million in 2013 and is expected to grow at a CAGR of 6.8% to reach $1944.7 million by 2018. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of 60% of the global Neurointerventional devices market, followed by support devices (17%), cerebral balloon angioplasty & stenting systems (15%) and neurothrombectomy devices (8%) in 2012..
The report “Neurointerventional Devices Market forecast, 2012-2018 “analyzes the market categorizes the neurointerventional devices market for devices by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). All of these segments experienced a positive growth till 2018 with an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $0.9 and $0.2 billion, aneurysm coiling and cerebral angiography and stenting technique segments have been contributing around 60% and 16% in terms of value towards total Neurointerventional devices market. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Aneurysm Coiling , Arteriovenous Malformation Embolization & Fistula embolization .
Procedure Volume growth is significantly higher in Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries, fast disease progression, higher prevalence, broadening insurance coverage, expanding private healthcare sector and increasing awareness amongst people.
North America dominates the overall neurointerventional devices market. Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific and Latin American market. The Asian Neurointerventional devices market is expected to grow at a growth rate of 14.8% to reach $3882.06 million by 2018. The high prevalence in Asia is because of maximum aging population whereas in North America and Europe it’s because of high diabetes and obese population.
The report also provides an extensive competitive landscaping of companies operating in Neurointerventional devices market. The main companies operating in Neurointerventional devices market and extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.)..
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of ischemic and hemorrhagic stroke
- Country specific Patient pool of ischemic and hemorrhagic stroke
- Disease progression (Pattern analysis)
Procedure Volume Data
- Bilateral and Unilateral Neurointerventional procedures performed annually in each Country tracked till sub-segment level
- Number of neurothrombectomy, cerebral balloon angioplasty & stenting procedures performed in each country
Surgeons/Physicians Forum
- Fast turn-around analysis of Surgeons response to market events and trends
- Pattern analysis of usage of Aneurysm Coiling, Arteriovenous Malformation Embolization & Fistula embolization by Physicians
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost analysis of Neurointerventional Devices in major countries
- neurothrombectomy, cerebral balloon angioplasty & stenting procedural investment in major countries for Neurointerventional Devices
Competitive Intelligence
- The company share analysis of Neurointerventional Devices top players in the region
- The crucial developments and strategies of companies inculcating in their portfolio of Neurointerventional Devices market
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Neurothrobectomy Devices Neurothrobectomy Devices and Cerebral Ballon Angioplasty & Stenting Sytems, |
Upcoming | |
Cerebral Ballon Angioplasty & Stenting Sytems Cerebral Ballon Angioplasty & Stenting Sytems and Neurothrobectomy Devices, |
Upcoming | |
Embolization Devices Embolization Devices and Neurothrobectomy Devices, |
Upcoming | |
Support Devices Support Devices and Neurothrobectomy Devices, |
Upcoming | |
Suction/Aspiration Device Suction/Aspiration Device and Clot Retriever and Snare Devices adds... |
Upcoming | |
Clot Retriever Clot Retriever and Suction/Aspiration Device and Snare... |
Upcoming | |
Snare Devices Snare Devices and Suction/Aspiration Device and Clot... |
Upcoming | |
Carotid Artery Stents Carotid Artery Stents and Embolic Protection Systems adds up to total |
Upcoming | |
Embolic Protection Systems Embolic Protection Systems and Carotid Artery Stents adds up to total |
Upcoming | |
Embolic Coil Embolic Coil and Flow Diversion Devices and Liquid... |
Upcoming | |
Flow Diversion Devices Flow Diversion Devices and Embolic Coil and Liquid Embolic... |
Upcoming | |
Liquid Embolic Agents Liquid Embolic Agents and Embolic Coil and Flow Diversion... |
Upcoming | |
Microcatheters Microcatheters and Microguidewires adds up to total Support... |
Upcoming | |
Microguidewires Microguidewires and Microcatheters adds up to total Support Devices... |
Upcoming | |
Distal Filter Devices Distal Filter Devices and Balloon Occlusion Devices adds up to total |
Upcoming | |
Balloon Occlusion Devices Balloon Occlusion Devices and Distal Filter Devices adds up to total |
Upcoming | |
Bare Platinum Detachable Coil Bare Platinum Detachable Coil and Coated Detachable Coil adds up to total |
Upcoming | |
Coated Detachable Coil Coated Detachable Coil and Bare Platinum Detachable Coil adds up to total |
Upcoming | |
Asian Neurointerventional Radiology Devices The Asian neurointerventional radiology devices market, mainly driven by gradual technological evolution, growing aging and obese population, rising patient pool of ischemic and hemorrhagic stroke, and increasing demand for minimally invasive surgical procedures This market is expected to grow at a growth rate of $125.5 million in 2012 and is expected to grow at a CAGR of 14.8% to reach $268.6 million by 2018. The market is divided into five segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). Major players extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.). |
Upcoming | |
North American Neurointerventional Radiology Devices The North American Neurointerventional radiology Devices Market, mainly driven by gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. The North american neurointerventional radiology devices market is estimated to be $678.3 million in 2013 and is expected to grow at a CAGR of 5.5% to reach $886.2 million by 2018. The market devided by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). Major players extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.). |
Upcoming |